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Summary
Velo-cardio-facial syndrome (VCFS) is themost common
microdeletion syndrome in humans. It occurs with an
estimated frequency of 1 in 4,000 live births. Most cases
occur sporadically, indicating that the deletion is recur-
rent in the population. More than 90% of patients with
VCFS and a 22q11 deletion have a similar 3-Mb hemizy-
gous deletion, suggesting that sequences at the break-
points confer susceptibility to rearrangements. To define
the region containing the chromosome breakpoints, we
constructed an 8-kb–resolution physical map. We iden-
tified a low-copy repeat in the vicinity of both break-
points. A set of genetic markers were integrated into the
physical map to determine whether the deletions occur
within the repeat. Haplotype analysis with geneticmark-
ers that flank the repeats showed that most patients with
VCFS had deletion breakpoints in the repeat. Within the
repeat is a 200-kb duplication of sequences, including
a tandem repeat of genes/pseudogenes, surrounding the
breakpoints. The genes in the repeat are GGT, BCRL,
V7-rel, POM121-like, and GGT-rel. Physical mapping
and genomic fingerprint analysis showed that the repeats
are virtually identical in the 200-kb region, suggesting
that the deletion is mediated by homologous recombi-
nation. Examination of two three-generation families
showed that meiotic intrachromosomal recombination
mediated the deletion.
Introduction
A number of congenital-anomaly disorders are associ-
ated with rearrangements of human chromosome
22q11. The most common is velo-cardio-facial syn-
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drome (VCFS; MIM 192430), an autosomal dominant
disorder characterized by craniofacial anomalies, heart
defects, and learning disabilities (Shprintzen et al. 1978).
It is phenotypically related to DiGeorge syndrome (DGS;
MIM 188400) (DiGeorge 1965), a more severe disorder.
DGS is characterized by hypocalcemia, aplasia, or hy-
poplasia of the thymus gland, as well as by the clinical
findings of VCFS. Patients with VCFS and DGS have
similar 22q11 deletions, suggesting that these disorders
have the same etiology (Driscoll et al. 1992; Scambler
et al. 1992). The estimated occurrence of VCFS/DGS is
1 in 4,000 live births, making it the most common mi-
crodeletion disorder in humans (Burn and Goodship
1996). Most cases occur sporadically in the population,
indicating that the 22q11 region is prone to rearrange-
ments. To define the deletions among patients, we con-
structed a YAC-contig–based physical map of a 5-Mb
region on 22q11 (Collins et al. 1995; Morrow et al.
1995). A total of 15 consecutive highly polymorphic
genetic markers, which were part of the physical map,
were used to genotype 151 patients with VCFS (Carlson
et al. 1997). We found that 83% of the patients had a
detectable 22q11 deletion. Haplotype analysis revealed
that 90% of the VCFS patients with a deletion had a
similar 3-Mb deletion (Carlson et al. 1997). The finding
that most of the deletions were similar suggested that
there might be sequences at the breakpoints that confer
susceptibility to chromosome rearrangements.
To determine the nature of the sequences at the prox-
imal and distal 3-Mb breakpoints, we defined the inter-
val containing them by constructing high-resolution
physical maps in their vicinity. The maps had an average
spacing of 8 kb between PCR-based markers. It was
previously shown by FISH that low-copy–repeat families
flanked the VCFS/DGS region on 22q11 (Halford et al.
1993). By using a physical mapping approach, we iden-
tified low-copy–repetitive sequences spanning both
breakpoint intervals and designated them “VCFS-
REPs.” Haplotype analysis of a large number of patients
with VCFS with genetic markers that flank the repeat
showed that the breakpoints occur within the repeat.
Both the proximal and distal VCFS-REPs have a com-
plex arrangement that contains a 200-kb region, com-
prised of a tandem set of genes and pseudogenes, flanked
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on either side by inverted subrepeats. Fingerprint anal-
ysis of clones that map to a 200-kb interval within the
proximal and distal VCFS-REPs indicated that the two
regions are almost identical in composition, suggesting
that homologous recombination between them could
mediate the rearrangement.
Subjects and Methods
FISH
The cosmid clone 57D10 was isolated from the grid-
ded LL22NC03 cosmid library (Roswell Park Cancer
Institute [RPCI]; P. de Jong, personal communication)
and used for FISH mapping. The DNA was purified on
Qiagen midi-preparation columns (Qiagen). To generate
a labeled probe, 1 mg of purified DNA (five slides) was
subjected to nick translation with biotin-16 dUTP
(GibcoBRL BioNick labeling system). The human re-
petitive sequences were blocked by prehybridization
with 50 g of CoT-1 DNA (GibcoBRL). Metaphase chro-
mosomes were prepared, and the probe was detected by
incubating the slides with an amplification sandwich of
fluorescein-labeled avidin, anti-avidin antibodies, and
fluorescein-labeled avidin and then by staining with pro-
pidium iodide (Oncor).
Construction of the Physical Map
To construct the high-resolution physical map, high-
density gridded membranes containing the 25X bacterial
artifical chromosome (BAC) (170 kb average insert size),
the 16X P1 artificial chromosome (PAC) (120 kb average
insert size), and the 8X flow-sorted cosmid libraries
(LL22NCO3, 40 kb average insert size) (RPCI; P. de
Jong, personal communication) were screened with
pools of 8–12 different 32P-radiolabeled PCR products
from genomic DNA (Random Primed DNA Labeling
Kit, Boehringer Mannheim). The positive clones were
isolated, and DNA was prepared (Qiagen). The marker
content of individual clones was verified by PCR analysis
using 50 ng of template DNA under standard amplifi-
cation conditions (Perkin-Elmer). The ends of the newly
identified clones were sequenced by means of ABI377
automated sequencing machines. Each of the sequences
was analyzed in Genbank by use of Blast Search, to
eliminate highly repetitive elements. Primers for PCR
were generated from the sequence (PRIMER Program)
and were used as probes to rescreen the libraries. The
genomic walking cycles were repeated until the gaps in
the physical map were closed.
Preparation of DNA from Individuals and Genotyping
Genomic DNA was prepared from 5 ml of peripheral
blood obtained from patients BM103 and BM413 and
their family members, with their informed consent (Hu-
man Genetics Program, Albert Einstein College of Med-
icine), by use of the Puregene protocol (Gentra) as de-
scribed elsewhere (Carlson et al. 1997). The blood
samples from each of the individuals in this study were
collected through a program approved by the internal
review board. A maximum of 15 highly polymorphic
genetic markers, from D22S420 to D22S257, were used
for genotyping each individual, as described elsewhere
(Carlson et al. 1997).
Results
Low-Copy Repeats Map to the VCFS Breakpoints
To define the interval containing the proximal and
distal breakpoints leading to the common 3-Mb de-
letion in patients with VCFS, we constructed a high-
resolution physical map. To initiate map assembly, se-
quence-tagged–site markers (Green and Olson 1990),
which were integrated into the YAC-contig–based phys-
ical map of 22q11 (Collins et al. 1995; Morrow et al.
1995), were used as probes to screen bacterial libraries
containing human genomic DNA inserts (Iaonnou et al.
1994). Surprisingly, clones that mapped to the proximal
breakpoint interval were positive for markers known to
map to the distal breakpoint interval and vice versa.
These initial results suggested that both regions shared
a high degree of sequence homology or identity.
To directly examine whether sequences at the proxi-
mal and distal breakpoint intervals were repeated, we
performed FISH mapping with a cosmid from the distal
breakpoint interval, termed “57D10” (fig. 1). The as-
signment of this cosmid to the distal breakpoint interval
will be clarified later. The distance between the proximal
and distal breakpoint interval is 3 Mb, which is below
the resolution of metaphase FISH (fig. 1A). To separate
the proximal from the distal region, we performed FISH
on cells from a t(2;22) balanced translocation found in
a patient with VCFS/DGS, called “ADU” (Augusseau et
al. 1986). The ADU breakpoint has been cloned and
sequenced (Budarf et al. 1995) and has been integrated
into the physical map (Carlson et al. 1997). Patient ADU
has a translocation breakpoint 160 kb distal to the com-
mon VCFS proximal breakpoint, placing the proximal
and distal breakpoints on two distinct derivative chro-
mosomes. If the sequences in 57D10 are duplicated
in 22q11, three sets of signals would be observed, one
on the normal copy of chromosome 22, one on the
der(2) chromosome, and one on the der(22) chromo-
some. Three sets of signals were indeed detected on the
chromosomes of patient ADU (fig. 1B), supporting the
hypothesis that sequences in the vicinity of the break-
points were duplicated. We designated the low-copy re-
peats at the proximal and distal breakpoint intervals as
VCFS-REPs.
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Figure 1 FISH mapping with cosmid 57D10. A, Metaphase spread of an Epstein-Barr virus–transformed lymphoblastoid cell line from
a normal individual. Signals were detected with the 57D10 probe as indicated by the arrows. B, Metaphase spread of a lymphoblastoid cell
line from patient ADU that harbors the t(2;22) balanced translocation. A signal was detected with the 57D10 probe in the normal 22, der(2),
and der(22) chromosomes, as indicated by the arrows.
A physical map of the breakpoint sites was con-
structed by screening PAC and BAC libraries, establish-
ing their marker content and chromosome walking to
fill gaps. We found that none of the bacterial clones were
able to bridge the region containing the repeated mark-
ers. This indicated that the sizes of the proximal and
distal repeats were greater than the size of the largest
anchored clone. To unambiguously assign clones to ei-
ther the proximal or distal VCFS-REP, we developed a
unique anchored marker from within the repeated se-
quences. One marker was generated from the gamma-
glutamyl transpeptidase gene (GGT; Courtay et al.
1994), which maps to both the proximal and distal
breakpoint intervals (fig. 2). Single-nucleotide polymor-
phisms in the GGT genes (Courtay et al. 1994; Collins
et al. 1997) were used to distinguish the proximal from
the distal copy (fig. 3). Restriction-fragment analysis of
a 390-bp PCR product from a segment of theGGT genes
(GGT-AMP) showed that the GGT genes in the proxi-
mal and distal copies of the VCFS-REPs belonged to the
class termed “GGT.2” (Collins et al. 1997). However,
there were three distinct genes reported to belong to the
GGT.2 class—genes 3, 11, and 13. To determine which
of the GGT.2 genes mapped to the VCFS breakpoints,
we digested the GGT.2-AMP PCR products with
Bsp1286E, and two distinct restriction patterns were
identified. These restriction patterns can be used to dis-
tinguish gene 3 from gene 11 or 13 (fig. 3A). To further
distinguish genes 11 and 13, the GGT.2-AMP PCR prod-
ucts were sequenced (fig. 3B). By using this approach,
we determined that clones anchored to the distal VCFS-
REP contain GGT.2–gene 3, and those that anchor
to the proximal VCFS-REP contain GGT.2–gene 13.
This strategy allowed us to construct a complete se-
quence-ready physical map of the breakpoint regions.
This map, estimated to cover 720 kb in the proximal
region and 920 kb in the distal region, contained 103
and 92 markers, respectively, and provides an average
resolution of 8.5 kb.
A 200-kb Region of Homology Maps to the Proximal
and Distal VCFS-REPs
The proximal and distal VCFS-REPs have a complex
organization (fig. 2). Subsets or subrepeats of markers
containing anonymous genomic sequences are grouped
together and repeated multiple times in both the prox-
imal and distal VCFS-REPs. In addition, a cluster of
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Figure 2 Sequence-ready physical map of the 3-Mb breakpoint intervals. The markers used to construct the physical map are indicated
above the line representing chromosome 22q11. The orientation of the map is centromere to telomere, left to right. The polymorphic genetic
markers (circles; asterisk [*] above), expressed sequences or genes (triangles), and anonymous genomic markers (squares) are shown. The PCR
markers derived from the ends of bacterial clones are denoted by an “X.” VCFS-REP markers are contained within the boxed areas. Markers
oriented by Southern hybridization analysis are demarcated by numbered brackets. The numbers under the bracketed segments indicate specific
EcoRI restriction fragments. The shaded boxes demarcate the 200-kb region with highest homology between the proximal and distal VCFS-
REPs. The arrows in the shaded boxes denote the orientation of the inverted subrepeats. The clones that constitute the minimal tiling path in
the 200-kb region are boxed in black. The clones that were used for fingerprint analysis are boldface and in a larger font. The sc11.1a markers,
444P24Sp6–D22S1660, are demarcated with a bar above the markers and are immediately adjacent to the proximal VCFS-REP (shaded gray).
Segments of the map containing regions where individual markers could not be ordered are indicated by a dark line underneath the markers.
The double-dashed line under markers D22S287E–699J1T7 indicates that the marker order is known from available sequences (University of
Oklahoma, Human and Mouse Genomic Sequencing database; Genbank accession number AC002051).
genes/pseudogenes, including GGT, is also present
within the repeats. To determine the orientation of the
subrepeats, genomic DNA was isolated from bacterial
clones that mapped to the intervals and was digested
with EcoRI. Each of the markers within the subrepeats
was used as a probe on Southern blots containingEcoRI-
digested clones from the proximal and distal regions.
The EcoRI fragments and the corresponding posi-
tive markers are designated by a set of numbered brack-
ets (fig. 2). Although most of the markers exam-
ined hybridized to the same size fragment in all the
clones that were tested, two of them—D22S131 and
599O20Sp6—consistently produced characteristic re-
striction fragments among the different loci. The sizes
of the EcoRI fragments are indicated along with the
marker, as depicted infigure 2. By incorporating the
Southern blot data into our maps, we were able to dis-
tinguish among the subrepeats to definitively assign
clones to the correct interval. Furthermore, we deter-
mined that the orientation of the subrepeats, which im-
mediately flank the cluster of genes/pseudogenes, is in-
verted with respect to each other.
The region of highest homology between the proximal
and distal VCFS-REPs constitutes a 200-kb region con-
taining the tandem cluster of genes/pseudogenes, flanked
by a set of inverted subrepeats. The 200-kb size was
calculated by addition of the minimum tiling path of
clones that constitutes the shaded interval infigure 2. For
the proximal VCFS-REP, two clones (PACs 99506 and
699J1) overlap. PAC 995O6 is positive for 28 markers,
and PAC 699J1 is positive for 27 markers. Both clones
have an average insert size of 120 kb and an average
spacing between markers of 4.4 kb (240 kb/55 markers).
The proximal shaded interval contains 46 markers,
which represents a physical distance of ∼200 kb
( kb). For the distal VCFS-REP, the minimal46# 4.4
tiling path includes BAC379N11 and PAC413M7.
BAC379N11 is positive with 34 markers and is esti-
mated to be 170 kb. PAC413M7 is positive with 32
markers and is estimated to be 120 kb. The average
resolution is 4.4 kb (290 kb/66 markers). The distal
shaded interval in figure 2contains 46 markers and is
estimated to be 200 kb, the same as for the proximal
interval.
To assess the extent of homology between the repeats,
individual clones that mapped to the proximal and distal
breakpoint intervals were fingerprinted by use of EcoRI
digestion (fig. 4). The restriction fragments of cosmids,
BACs, and PACs, which were positive with a similar set
of markers, were directly compared. The restriction pat-
terns were almost identical among the clones from the
proximal and distal repeats. These results provided fur-
ther confirmation of the mapping data, indicating that
the organization and composition of the proximal and
distal VCFS-REPs were nearly identical over a 200-kb
stretch.
Proximal and Distal Breakpoints Occur within the
VCFS-REP
To determine whether patients with VCFS with the 3-
Mb deletion have breakpoints within the repeats, we
integrated the genetic markers into the physical map (fig.
2). Two genetic markers, D22S427 and D22S1638, flank
the proximal VCFS-REP. D22S427 is not deleted in pa-
tients with VCFS, whereas D22S1638 is deleted in all
patients with VCFS with the 3-Mb deletion (Carlson et
al. 1997), indicating that the proximal deletion break-
point occurs between these two genetic markers. An-
other type of repeat, the sc11.1 locus, maps to two
regions on 22q11 (Lindsay et al. 1993). The more cen-
tromeric locus, sc11.1a, is adjacent to the proximal
VCFS-REP (fig. 2). Approximately 7% of patients with
VCFS with a 22q11 deletion have the same proximal
breakpoint as those with a 3-Mb deletion but have a
nested distal breakpoint resulting in a 1.5-Mb deletion
(Carlson et al. 1997). The sc11.1b locus maps to the
region adjacent to the 1.5-Mb distal deletion breakpoint
interval (Funke et al. 1999). Both loci, sc11.1a and
sc11.1b, are deleted in all patients with VCFS with either
the 1.5- or 3-Mb deletion (Lindsay et al. 1995). There-
fore, the proximal deletion breakpoint occurs within the
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Figure 3 Analysis of the GGT.2 genes. A, GGT.2 clones were mapped to either the proximal or distal VCFS-REP by generation of the
GGT-AMP PCR products, followed by restriction digestion with Bsp1286E endonuclease. Clones that mapped to the distal VCFS-REP contained
GGT.2–gene 3 and produced characteristic restriction fragments. Clones that mapped to the proximal VCFS-REP contained GGT.2–gene 13,
which could not be distinguished from GGT.2–gene 11. B, GGT-AMP PCR products were sequenced to distinguish gene 11 from gene 13. The
position of the nucleotide sequences refers to GGT.5–gene 6 (Courtay et al. 1997).
repeat, flanked by D22S427 on the centromeric side and
by the sc11.1a locus on the telomeric side.
The distal breakpoint occurs between the highly poly-
morphic genetic markers D22S1709 and D22S308 (fig.
5; Carlson et al. 1997). D22S308 maps 520 kb telomeric
to the distal end of the repeat (Kawasaki et al. 1995).
To narrow the breakpoint interval we genotyped several
patients with the 3-Mb deletion and their unaffected
parents with 336L8(CA), a biallelic marker that contains
a CA tandem repeat and that immediately flanks the
distal VCFS-REP (fig. 2). The level of heterozygosity is
.22 (14/64) among the unaffected individuals and .25
(17/68) for the patients with VCFS. These results show
that the breakpoint occurs proximal to 336L8(CA) and,
therefore, must lie within the distal VCFS-REP.
A Cluster of Genes and Pseudogenes Maps to the
VCFS-REP
As part of the physical mapping process, each of the
insert ends of the bacterial clones was sequenced and
analyzed for homology to known genes (Genbank, Blast
Search). We found that a set of five genes/pseudogenes
maps to the proximal and distal VCFS-REPs (fig. 2).
They include GGT-rel, GGT, V7-rel, POM121-like
(POM121L), and BCRL (fig. 2). GGT-rel shares 40%
amino acid identity with GGT, and both function as
gamma-glutamyl transpeptidases (Heisterkamp et al.
1991). The GGT genes that map to the proximal and
distal VCFS-REPs are transcribed but contain frame-
shifts indicating that they do not encode functional prod-
ucts (Collins et al. 1997). The V7-rel gene is related in
sequence to V7, a gene that encodes a leukocyte surface
protein that participates in T-cell activation and that
maps to chromosome 1p13 (Ruegg et al. 1995). The
POM121L gene product is related to a rat nuclear-
membrane protein for which the function is not known
(Soderqvist et al. 1996). All four genes map to 22q11,
as well as to other chromosomes (Heisterkamp et al.
1991; Ruegg et al. 1995; Kawasaki et al. 1995). In con-
trast, the BCR and related BCRL genes map only to
22q11 (Budarf et al. 1988). The BCR gene is of partic-
ular interest because a BCR/ABL fusion gene product
results from a t(9;22) translocation implicated in acute
lymphocytic leukemia and chronic myelogenous leuke-
mia (MIM 151410) (de Klein et al. 1982; Shtivelman et
al. 1985).
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Figure 4 EcoRI fingerprint analysis. Genomic DNA isolated from proximal bacterial clones, labeled “P” (cosmid 32C12, BAC 273C15,
and PAC 995O6), and distal clones, labeled “D” (cosmid 84C12, BAC 379N11, and PAC 823B24), taken from the 220-kb region of highest
homology between the proximal and distal VCFS-REPs, were digested with EcoRI and separated on a 0.8% agarose gel. The 1-kb ladder
(NEBiolabs) size standard (labeled “M”) is included. Arrows demarcate the positions of the bacterial vector DNA fragments. The positions of
the EcoRI vector fragments were determined from the sequences available for the vectors pBACe3.6 and pCY2PAC2 (RPCI), for the BACs and
PACs, respectively. To identify cosmid-specific fragments, several nonoverlapping cosmid clones were compared by fingerprint analysis. The gel
was stained with SYBR gold (Molecular Probes) and analyzed by fluoroimaging (Molecular Dynamics).
Mechanism of 22q11 Rearrangements Leading to
Deletions
The presence of highly homologous low-copy repeats
at the breakpoints on 22q11 indicates that homologous
recombination between the repeats mediates the dele-
tion. To understand the mechanism responsible for
generating deletions in 22q11, we performed haplotype
analysis on two separate three-generation families of pa-
tients with VCFS with the 3-Mb deletion (fig. 5). The
positions of the VCFS-REPs, with respect to the genetic
markers, is depicted in figure 5. Genetic markers that
flank either side of the deletion were inherited from a
single chromosome 22 in both cases. For BM103, the
chromosome 22q11 region originated from her grand-
father, BM110. For BM413, it originated from her
grandmother, BM547. These data indicate that in both
sporadic cases of VCFS an intrachromosomal homolo-
gous recombination event occurred, leading to the 3-Mb
deletion.
Discussion
The 22q11 region is prone to rearrangements leading
to congenital-anomaly disorders. The most common re-
arrangement of 22q11 is the 3-Mb hemizygous deletion
detected in VCFS/DGS patients. In this report, we
showed that the chromosome breakpoints occurred
within two complex repeats that are 3 Mb apart and
that the deletions arose by homologous recombination
events. In the two VCFS cases we examined and in 10
additional cases, both intra- and interchromosomal ho-
mologous recombination mechanisms mediate the 3-Mb
deletion (Baumer et al. 1998). Although the deletions
were reported to occur by both mechanisms, most cases
were because of interchromosomal recombination. A
high level of unequal meiotic crossover has also been
reported for Charcot-Marie-Tooth disease type 1A
(CMT1A; MIM 118220) (Lopes et al. 1997) and the
Williams-Beuren Syndrome (WBS; MIM 194050) (Dut-
ley and Schinzel 1996).
Analysis of the duplication breakpoints for another
22q11 disorder, termed “cat-eye syndrome” (CES; MIM
115470), supports the conclusion that unequal meiotic
crossover between the VCFS-REPs generates disease-re-
lated rearrangements. CES is a rare chromosomal dis-
order characterized by ocular coloboma, anal atresia,
conotruncal heart defects, and characteristic craniofac-
ial anomalies (Schinzel et al. 1981). Patients with CES
have a supernumerary bisatellited marker chromosome
22pter-q11, resulting from an inverted duplication of the
proximal 22q11 region (Schinzel et al. 1981). Two dis-
tinct CES chromosome duplication breakpoints have
been described, a smaller type I and a larger type
II breakpoint (McTaggart et al. 1998). The type I
CES breakpoints occur between the genetic markers
D22S427 and D22S1638 (McTaggart et al. 1998), the
same genetic markers that flank the proximal VCFS-REP
and that mediate the proximal chromosome deletion
breakpoint in 97% of VCFS deletions (fig. 5). The type
II CES breakpoints occur in the interval flanked by
Figure 5 Haplotype analysis of three generations. Haplotype analysis was performed on two patients with VCFS (BM103 and BM413) and their family members. Three generations were
genotyped by means of a set of ordered genetic markers that span the 22q11 region (Carlson et al. 1997). The positions of the proximal and distal VCFS-REPs are shown with respect to the genetic
map. The markers that were tested for each family are indicated. The origin of the rearranged chromosome is indicated (blackened bar).
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D22S1709 and D22S636, which maps near D22S938
(fig. 2; McTaggart et al. 1998). This is in the same in-
terval as the 3-Mb distal deletion breakpoint associated
with VCFS (fig. 5). In addition, some of the rearrange-
ments are asymmetric; the bisatellited chromosome oc-
curs as a result of one type I and one type II breakpoint
in individual patients (McTaggart et al. 1998). The maps
we created for these breakpoint intervals indicate that
the breakpoints for CES occur near or within the prox-
imal and distal VCFS-REPs. The complex organization
within these repeats could conceivably mediate a mul-
titude of rearrangements by homologous recombination
events. There are several GGT/BCRL clusters that span
the 22q11 region that may represent additionalmembers
of the low-copy repeats described here (Heisterkampand
Groffen 1988; Collins et al. 1997). Other congenital
disorders, such as der(22) syndrome (Funke et al. 1999)
and more-rare deletion breakpoints leading to VCFS/
DGS, may be mediated by additional copies of this re-
peat on 22q11.
Low-copy repeats have been implicated in mediating
rearrangements of other human disorders. The best char-
acterized of these is CMT1A/hereditary neuropathywith
liability to pressure palsies (HNPP; MIM 162500) and
two peripheral neuropathies associated with a duplica-
tion or deletion of the same region on chromosome
17p11.2-12 (Lupski et al. 1991; Pentao et al. 1992). A
24-kb duplication of sequences flanking a 1.5-Mb region
has been implicated in the rearrangements (Chance et
al. 1994). Adjacent to this interval, but unrelated in se-
quence, is the Smith-Magenis syndrome (MIM 182290)
region, which maps to 17p11.2 (Smith et al. 1986;
Greenberg et al. 1991). Three copies of a 200-kb repeat
map to the interval (Chen et al. 1997). The two outer
repeats are implicated in mediating the 5-Mb common
deletion associated with the disorder. A duplication of
sequences may also be responsible for other deletion dis-
orders, including WBS on 7q11.23 (Osborne et al. 1996;
Perez Jurado et al. 1998) as well as Prader-Willi syn-
drome (MIM 176270) and Angelman syndrome (MIM
105830) on 15q11-13 (Wandstrat et al. 1998). It is likely
that similar mechanisms mediate the rearrangements as-
sociated with VCFS and other rearrangement disorders.
Repetitive sequences may contribute to the inherent in-
stability of these chromosomal regions.
Since most patients with VCFS/DGS have a similar 3-
Mb deletion, it is possible that there are sequenceswithin
the VCFS-REPs that are particularly prone to rearrange-
ment. In the case of the HNPP deletion on 17p11.2-12
(Reiter et al. 1996, 1998), a hot spot of recombination
occurs in a 557-bp region of sequence identity between
the two repeats (Reiter et al. 1998). The extent of the
sequence identity may be a factor in determining the
location of the breakpoint in the repeats (Liskay et al.
1986; Waldman et al. 1988). Of interest, a mariner
transposon-like element is near the hot spot for CMT1A/
HNPP rearrangements, and strand exchange has been
suggested to be mediated by a transposase (Reiter et al.
1996). Genomic fingerprinting studies (fig. 4) indicated
that a 200-kb region within the proximal and distal
VCFS-REPs share a high degree of homology, implicat-
ing this region as a target for homologous recombination
events. The fact that the subrepeats are present multiple
times within each VCFS-REP could increase the prob-
ability of misalignment. Alternatively, the breakpoints
may occur in the vicinity of the tandem set of genes/
pseudogenes in the VCFS-REP, which would suggest that
a correlation exists between transcriptionally active
regions and homologous recombination events. To de-
termine whether the chromosome breakpoints occur in
clustered regions or at random sites of sequence ho-
mology, direct sequencing of the repeats and ascertain-
ment of where the breakpoints occur in individual pa-
tients are needed.
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